Sign In
Buy FMS
$25.66
-0.0400 (-0.156%)
At Close: Jul 31, 2026
Fresenius SE & Co KGaA (FRA:FRE) PT Set at €47.00 by Goldman Sachs Group
10:18am, Friday, 17'th Apr 2020
Fresenius SE & Co KGaA (FRA:FRE) received a €47.00 ($54.65) price target from research analysts at Goldman Sachs Group in a report released on Friday, Borsen Zeitung reports. The brokerage presently
Fresenius Medical upgraded to Conviction Buy from Buy at Goldman Sachs FMS
10:01am, Friday, 17'th Apr 2020
Fresenius Medical upgraded to Conviction Buy from Buy at Goldman Sachs Goldman Sachs FMS
Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €80.00 Price Target by Goldman Sachs Group Analysts
06:32am, Friday, 17'th Apr 2020
Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been given a €80.00 ($93.02) price objective by equities research analysts at Goldman Sachs Group in a research report issued to clients and invest
Analysts' Recent Ratings Changes for Fresenius Medical Care AG & Co. KGaA (FME)
05:22am, Friday, 17'th Apr 2020
Fresenius Medical Care AG & Co. KGaA (ETR: FME) recently received a number of ratings updates from brokerages and research firms: 4/15/2020 – Fresenius Medical Care AG & Co. KGaA was given a new €
The "Global Dialysis Market, Dialysis Patients, by Type (Hemodialysis, Peritoneal Dialysis), Product & Services (Equipments, Consumables, Services), End-Use, Regions, Company Analysis, Recent Developm
Head to Head Contrast: Glaukos (NYSE:GKOS) & FRESENIUS SE &/S (NYSE:FSNUY)
05:56am, Thursday, 16'th Apr 2020
FRESENIUS SE &/S (OTCMKTS:FSNUY) and Glaukos (NYSE:GKOS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommen
New York, April 15, 2020 -- Reportlinker.com announces the release of the report "Nephrology Devices Market Research Report by Device - Global Forecast to 2025" -.
Dublin, April 15, 2020 -- The "Global Dialysis Market, Dialysis Patients, by Type (Hemodialysis, Peritoneal Dialysis), Product & Services (Equipments, Consumables,.
New York, April 13, 2020 -- Reportlinker.com announces the release of the report "Nephrology Device Market Research Report by Device - Global Forecast to 2025" -.
SunTrust Robinson Humphrey Maintains Buy on Fresenius Medical Care, Lowers Price Target to $42
01:03pm, Monday, 13'th Apr 2020Analysts Offer Insights on Services Companies: WW Grainger (GWW), Alibaba (BABA) and Community Health (CYH)
11:09am, Monday, 13'th Apr 2020
Companies in the Services sector have received a lot of coverage today as analysts weigh in on WW Grainger (GWW), Alibaba (BABA) and Community Health
RBC Capital Sticks to Their Buy Rating for Tenet Healthcare (THC)
11:07am, Monday, 13'th Apr 2020
RBC Capital analyst Frank Morgan maintained a Buy rating on Tenet Healthcare (THC) today and set a price target of $26.00. The company's shares closed
RBC Capital Sticks to Its Buy Rating for Universal Health (UHS)
11:04am, Monday, 13'th Apr 2020
RBC Capital analyst Frank Morgan maintained a Buy rating on Universal Health (UHS) today and set a price target of $145.00. The company's shares closed
Analysts' Top Healthcare Picks: Fortress Biotech (FBIO), Sarepta Therapeutics (SRPT)
11:03am, Monday, 13'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Fortress Biotech (FBIO), Sarepta Therapeutics (SRPT) and
Analysts’ Top Healthcare Picks: Fortress Biotech (FBIO), Sarepta Therapeutics (SRPT)
11:03am, Monday, 13'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Fortress Biotech (
FBIO
–
Research Report
), Sarepta Therapeutics (
SRPT
–
Research Report
) and HC
